ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Minimal Residual Disease (MRD) Testing"
Episode Synopsis
In this installment of the FLASCO OncoPod, we explore the critical role of Minimal Residual Disease (MRD) testing in advancing cancer care with Dr. Ivan Borrello, a distinguished oncologist from Tampa General Hospital.Dr. Borrello dives into the science behind MRD testing, its applications in hematologic malignancies, and how it informs treatment decisions and long-term patient outcomes. Gain expert insights on the latest advancements in MRD technology and its impact on precision medicine in oncology.Join us for an enlightening conversation designed for oncology professionals dedicated to staying at the forefront of cancer diagnostics and care.
More episodes of the podcast FLASCO OncoPod
The Missing Treatment Layer: Daily Support That Improves Treatment Tolerance and Completion
06/11/2025
Insights & Understanding of PNH
22/07/2025
Advances in MDS
07/05/2025
New Immunotherapy Options for GE Cancers
21/03/2025
Updates in IDHm Gliomas - Part II
25/02/2025
In God we trust